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Abstract
Background: The role of technology in the self-management of type 1 diabetes mellitus (T1DM) among children
and young people is not well understood. Interventions should aim to improve key diabetes self-management
behaviours (self-management of blood glucose, insulin administration, physical activity and dietary behaviours) and
prerequisites (psychological outcomes and HbA1c) highlighted in the UK guidelines of the National Institute for
Health and Care Excellence (NICE) for management of T1DM. The purpose was to identify evidence to assess the
effectiveness of technological tools in promoting aspects of these guidelines amongst children and young people.
Methods: A systematic review of English language articles was conducted using the following databases: Web of
Science, PubMed, Scopus, NUSearch, SAGE Journals, SpringerLink, Google Scholar, Science Direct, Sport Discus,
Embase, Psychinfo and Cochrane Trials. Search terms included paediatric, type one diabetes, technology,
intervention and various synonyms. Included studies examined interventions which supplemented usual care with a
health care strategy primarily delivered through a technology-based medium (e.g. mobile phone, website, activity
monitor) with the aim of engaging children and young people with T1DM directly in their diabetes healthcare.
Studies did not need to include a comparator condition and could be randomised, non-randomised or cohort
studies but not single-case studies.
Results: Of 30 included studies (21 RCTs), the majority measured self-monitoring of blood glucose monitoring
(SMBG) frequency, clinical indicators of diabetes self-management (e.g. HbA1c) and/or psychological or cognitive
outcomes. The most positive findings were associated with technology-based health interventions targeting SMBG
as a behavioural outcome, with some benefits found for clinical and/or psychological diabetes self-management
outcomes. Technological interventions were well accepted by children and young people. For the majority of
included outcomes, clinical relevance was deemed to be little or none.
Conclusions: More research is required to assess which elements of interventions are most likely to produce
beneficial behavioural outcomes. To produce clinically relevant outcomes, interventions may need to be delivered
for at least 1 year and should consider targeting individuals with poorly managed diabetes. It is not possible to
determine the impact of technology-based interventions on insulin administration, dietary habits and/or physical
activity behaviour due to lack of evidence.
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Background
Type 1 diabetes mellitus (T1DM) is increasing in preva-
lence in the UK, affecting over 30,000 children and young
people and so diabetes management typically begins early
in life [1]. The management of T1DM is complex and
involves key self-management behaviours outlined in
national recommendations (NICE), including: self-moni-
toring of blood glucose (SMBG), insulin administration,
dietary management and regular physical activity, with the
aim of maintaining optimal blood glucose levels [2]. Fur-
ther, NICE guidance highlights key psychological and clin-
ical (HbA1c) prerequisites to self-management behaviour
[2]. A focus on any or all of these components will lead to
improved diabetes control [2].
Technology-based interventions may augment
face-to-face interactions with therapeutic staff, thereby of-
fering the potential to reduce the costs and dependence
on clinical staff of providing additional services beyond
regular clinical visits. Efficacious delivery of policy objec-
tives in clinical care through technology-based mediums
could therefore contribute to reducing the economic bur-
den of T1DM. Technology-based interventions also aug-
ment standard services, increasing access and availability
of evidence-based practices outside clinical settings. This
could be a useful adjunct to the usual care of children and
young people with T1DM, particularly as increasing inde-
pendence and self-reliance is a concern amongst this
group [3]. Prior non-systematic reviews [4–6] demon-
strate that technology-based interventions promoting
diabetes self-management may be acceptable to chil-
dren and young people with T1DM, and have the po-
tential to improve certain outcomes and behaviours
(e.g. HbA1c, blood glucose monitoring).
The purpose of this systematic review is to critically
analyse the literature assessing the effectiveness of
technology-based interventions for children and young
people with T1DM on the diabetes self-management be-
haviours and prerequisites that are highlighted by
current treatment guidelines as being crucial for effect-
ive diabetes management [2]. In this way, this review will
identify aspects of national guidance which may be ef-
fectively promoted to children and young people using
technological tools.
Methods
Reporting of the systematic review followed the PRISMA
(Preferred Reporting Items for Systematic reviews and
Meta-Analyses) checklist [7].
Eligibility
Peer-reviewed studies published in the English language
prior to May 2017 were considered. Eligibility criteria
were as follows:
 Participants: Aged between 2 and 18 years or
described as ‘paediatric’, with a clinical diagnosis of
T1DM (with or without comorbidities). For the
purpose of this review this is also the definition of
children and young people [8].
 Intervention: Interventions that supplement usual
care with a health care strategy primarily delivered
through a technology-based medium for the engage-
ment of patients in self-management behaviours.
Studies using continuous glucose monitoring (CGM)
were included when participants were still required to
conduct blood sugar checks and so they could be
deemed to be purely an informational tool used to
prompt self-management. Interventions targeting only
parents/primary caregivers or other health stake-
holders and not the child directly were excluded. In-
terventions which included a technology component
as a secondary medium for delivery were excluded.
 Comparison: A comparison condition was not
required for inclusion.
 Outcomes: Key behaviours (SMBG, insulin
administration, physical activity and diet),
prerequisites to behaviour (psychological supports)
and indicators of behaviour (HbA1c) as highlighted
by NICE guidance relating to diabetes self-
management [2].
 Study design: Randomised or non-randomised stud-
ies and cohort studies. Single-case studies were
excluded.
Search methods
Twelve databases were searched in April 2017 using the
strategy shown in Fig. 1. Full literature search terms with
their Boolean operators and the review protocol are avail-
able as supplementary materials (Supplementary Material
1 and 2). Titles were first screened for ineligibility (i.e. all
articles were carried forward to abstract screening unless
the title obviated exclusion). The reference lists of review
articles were searched by hand. Following de-duplication,
one reviewer (EK) screened abstracts of potentially rele-
vant articles. If the abstract suggested potential eligibility,
the full article was screened by EK and HQ independently.
Reasons for exclusion were recorded with disagreements
being resolved by a third reviewer (HB). Initial agreement
between authors was 76% however, after discussion clari-
fying criteria, there was 100% agreement without need for
the third reviewer.
Data extraction and study quality
The full text of each included study was read critically
by two reviewers independently (EK and HQ) and data
were tabulated (EK). The following items were included:
study details (author, publication year, aim, location, in-
clusion criteria), randomisation method (if applicable),
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study design, length of follow-up, comparison arm (if ap-
plicable), participant characteristics (gender, age, ethni-
city etc.), intervention details (type, intensity etc.),
recruitment and retention details (attrition rate, adher-
ence etc.), outcomes and statistical analysis. Correspond-
ing authors were contacted wherever insufficient detail
was reported in the article.
Measures of treatment effect
Reported data included effect sizes, 95% confidence
intervals (CI) and p values, mean values and standard
deviations (SD). A narrative synthesis approach was
used to summarise the results [9]. Co-author and lead
consultant at a paediatric diabetes clinic (TR) assessed
clinical relevance of findings.
Assessment of risk of bias
Evaluation of risk of bias in randomised controlled
trials (RCTs) followed recommendations of the
Cochrane Collaboration tool [10]. For
non-randomised studies the Risk of Bias in
Non-Randomised Studies of Interventions tool
(ROBINS-I tool) was applied [11].
Results
Included studies
The database searches yielded 1745 records (see Fig. 1).
After screening titles, 267 records remained. A further
13 records were identified following scrutiny of related arti-
cles. After de-duplication, 198 records remained. Abstract
screening led to 106 articles being excluded, leaving 92 arti-
cles to be screened in full. Of these, 30 studies met the inclu-
sion criteria for review. Details of included studies are
provided in Table 1. Following selection, studies were
grouped according to the behaviour, prerequisite or indica-
tor measured; SMBG, insulin administration, dietary man-
agement (e.g. dietary habits, monitoring behaviours for diet,
etc.), physical activity, psychological factors (e.g. self-efficacy)
and HbA1c. Studies including more than one relevant out-
come are included under more than one heading.
Interventions reporting on frequency of SMBG
Nine RCTs [12–20] and six non-RCTs [21–26] targeted
SMBG as an outcome. Full quality assessment details
are provided in the Tables. For the RCTs (Table 1), six
studies demonstrated low risk of bias [13, 15, 17–20],
two demonstrated moderate risk [12, 16] and for one
the level of risk was unclear [14]. For the non-RCTs
(Table 2), two demonstrated low risk of bias [23, 25],
one was low-moderate risk [24], one was moderate risk
[21] and two were high risk [22, 26].
Study characteristics Sample sizes ranged from 13 to
332 participants. The proportion of male participants
ranged from 15 to 83%. All samples were recruited from
paediatric clinics within one or more hospitals. The age
of participants from all but one study ranged from two
to 18 years. One study included participants aged 12–19
though participants were receiving treatment from a
paediatric clinic and described as youth.
Interventions included text messaging [n = 2 [24, 26]],
mobile phone applications [n = 2 [12, 21]], telephone-de-
livered behavioural therapy [n = 1 [19]], video tapes [n =
1 [20]], teleconferencing [n = 1 [16]], websites [n = 1
[13]], CGMs [n = 2 [23, 25]] and interactive online tools
[n = 5 [14, 15, 17, 18, 22]]. None of the studies men-
tioned a theoretical basis to the intervention.
Eleven of the studies employed a measurement of
SMBG frequency via glucometer download (n = 6), direct
daily telephone report (n = 1), retrospectively self-reported
questionnaire (n = 1), video upload (n = 1) or daily website
logs (n = 2). Four studies employed questionnaires to ob-
tain a rating of SMBG (Diabetes Self-Management Profile,
the Self-Care Inventory, 52-item Self-Management of
Type 1 Diabetes in Adolescence Scale).
Only 3/9 RCTs reported greater SMBG frequency in the
intervention group [13, 14, 16]. One RCT found
non-significant trends towards higher SMBG following
Fig. 1 Search Process
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intervention [20]. One RCT reported no change in SMBG
[18] and another reported no difference relative to a con-
trol group [15] following intervention. Two RCTs found
no change in SMBG following intervention even when
intervention engagement was considered [12, 17]. One
RCT found improved SMBG after intervention but no im-
provement relative to a control group [19].
Raiff and colleagues [13] reported an increase of 1.3
SMBG tests per day in participants receiving motiv-
ational interviewing and non-contingent rewards via a
webcam as opposed to face-to-face (p < 0.01). This in-
creased this to 1.96 tests per day (p < 0.01) when
contingent rewards were offered. Schiaffini and col-
leagues [14] reported an increase in SMBG tests per day
(5.5 ± 0.7 vs. 3.8 ± 0.7; p = 0.00) after 5 years, in a group
receiving monthly tele-contacts from their clinical team
relative to usual care alone. Harris and colleagues [16]
reported main effects of intervention from baseline to
12 weeks on adherence score following ten sessions of
behavioural family systems therapy delivered via Skype
(47.56 ± 12.78 to 53.22 ± 12.64, d = 0.45, p < 0.001) and 6
months (47.56 ± 12.78 to 50.94 ± 12.38, d = 0.18, p <
0.001). Nordfeldt and colleagues [20] found no changes in
SMBG frequency 24months after participants received
Table 2 Summary of clinical significance of findings relating to each main outcome of interest
Study Clinical significance of findings Clinical relevance
Self-monitoring of blood glucose (SMBG)
Clements & Staggs
(2017) [21]
Positive link found but 1/3 did not use app so it is likely that individuals who often SMBG use the
app rather than the app encouraging more SMBG. Factor of increase (2.3) reported but exact figures
not given so difficult to interpret i.e. could be increase from 1 to 2.3 which would impact very little
or 3 to 6.9 which would impact a great deal
Likely low
Harris et al.
(2015) [16]
25-item measure but does not give any measure of frequency and so impossible to say Unclear
Mulvaney et al.
(2012) [26]
1/3 of the cohort sent through no data, percentage of missed blood glucose tests reported
but actual frequency of SMBG not given and there is very high variability between the groups
i.e. some participants missed very few and some missed almost all tests thus for some findings
could be clinically meaningful but not for others
Unclear
Rachmiel et al.
(2015) [25]
Difference between continuous and intermittent users expected to have clinical significance
though would also lead to concomitant increase in discomfort from testing
Likely high
Raiff et al.
(2016) [13]
An increase of 2 to 4 tests per day would be expected to result in clinical improvements Likely some
Frequency of SMBG and insulin administration behaviour
Giani et al.
(2016) [23]
Improvements found amongst those who monitored regularly at the beginning of the study
but not those who initially monitored poorly. This suggests the intervention was effective
but only for those who did not need it
Likely low
Schiaffini et al.
(2016) [14]
Can be assumed that the intervention increased SMBG and insulin administration to a degree
that would be clinically significant. Unclear whether this is due to the electronic platform
or feedback from the clinical team
Likely some
HbA1c
Mulvaney et al.
(2012b) [39]
Nature of control group (matched historical control) is inappropriate to enable estimation
of clinical significance
Unclear
Pinsker et al.
(2011) [40]
No statistical significance found but demographic characteristics of the two groups are
not provided and so it is not clear if groups were matched
None
Rami et al.
(2006) [36]
No statistical significance reported None
HbA1c and self-efficacy
Franklin et al.
(2006) [34]
Improvements only reported in the intensive insulin group suggesting that the
technology-based intervention was not primarily responsible for differences
None
Self-efficacy
Berndt et al.
(2014) [30]
Measure likely taken immediately after receiving information from the clinical team and
so probably does not reflect real changes in self-efficacy
Likely low
Whittemore et al.
(2012) [18]
Intervention appears to have been no more effective than control Likely low
Need satisfaction (SDT)
Henkemans
et al. (2017) [42]
Unclear how findings relate to clinical outcomes Unclear
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either personalised video tapes and a brochure (2.7 ± 1.7
vs. 3.0 ± 1.5 times/day, p = n.s.), generalised videos (2.4 ±
1.5 vs. 2.8 ± 2.2) or standard care exhibited alone (2.6 ±
1.5, 2.8 ± 1.7, p = n.s.). Similarly, Goyal and colleagues [12]
found no difference in SMBG between a group given
access to a mobile phone application incentivising
SMBG (6.33 ± 0.45) and a control group (6.24 ± 0.57),
after 1 year (p = 0.90). Landau and colleagues [17] re-
corded SMBG frequency via monthly glucometer
downloads and found that download frequency was
similar every month for 6 months (specific values not
given) following an internet-based blood glucose mon-
itoring system. Two studies reported no difference in
self-reported SMBG between an internet coping skills
intervention and control after 6 months [31.8 ± 5.6 vs.
32.6 ± 5.9, p = 0.02 [14]], [− 0.02 ± 0.03, t = 0.49 vs.
-0.00 ± 0.03, t = 0.97, p = 0.65 [17]]. One study found
an improvement in self-reported SMBG over time
(42.3 to 48.4; F(1,27) = 16.3, p < 0.01) but no interven-
tion effect at 3 months after 36 behavioural therapy
sessions delivered via telephone [19].
Of the six non-RCTs, one found a non-significant
trend towards higher SMBG following intervention [22].
Four studies found greater SMBG frequency to be asso-
ciated with higher intervention use [21, 23, 25, 26]. One
study found no change in SMBG following intervention
at any measurement time-point even when intervention
engagement was considered [24].
Herbert and colleagues [24] found a trend towards
lower daily SMBG frequency after 6 weeks of receiving
daily educational text messages prompting SMBG (t(16)
= 17.3, p = 0.10). Mulvaney and colleagues [26] reported
significantly fewer missed blood glucose tests in a group
which adhered adequately to wearing a CGM than a
group which did not (16.81% vs. 36.50%; Mann-Whitney
U = 10.0, Z-statistic = 4.65, p < .001). Likewise, Rachmiel
and colleagues [25] and Giani and colleagues [23] found
that participants who consistently used their CGM ex-
hibited a higher frequency of daily SMBG than those
who did not after 1 year (10.6 ± 4.9 vs. 6.3 ± 2.8, p = 0.01)
and 6 months (> 8 times/day vs. < 8 times/day, p = 0.05),
respectively. Clements and Staggs [21] also found partic-
ipants increased their SMBG frequency by 2.3 each time
they synchronised data to a mobile phone application (p
< 0.01, CI = 1.82, 2.90). Dyal and colleagues [22] did not
perform a statistical analysis of data but reported daily
logs of SMBG to increase from < 3 a day at baseline to
as many as 34 logs a day after 5 weeks of accessing an
online interactive tool.
Interventions reporting on insulin administration behaviour
Two RCTs [12, 14] and two non-RCTs [23, 26] included
insulin administration behaviour as an outcome. Full qual-
ity assessment details are provided in the Tables. One
RCT demonstrated moderate risk of bias [12] and one
had unknown risk [14] (Table 1). Of the two non-RCTs,
one demonstrated low risk of bias [23] and another dem-
onstrated high risk of bias [26].
Study characteristics Sample sizes ranged from 29 to
92 participants. The proportion of male participants
ranged from 37.9 to 52%. All samples were recruited
from paediatric clinics at one or more hospitals. The age
of participants from three studies ranged from eight to
17 years. One study did not state the age range of partic-
ipants but described the sample as ‘paediatric’ and mean
age was 13 years.
Interventions included CGM [n = 1 [23]], a mobile
phone app [n = 1 [12]], an automated interactive telephone
response system [n = 1 [26]] and a website [n = 1 [14]]. All
of these studies also measured SMBG as an outcome.
Two studies reported the proportion of insulin doses
missed via meter download and self-report. One of these
also reported the proportion of incorrectly administered
doses, one study used self-reported self-initiated adjust-
ments to the insulin regimen and one study used
self-reported daily records of insulin boluses per day.
One RCT found improvements to insulin administration
following intervention [14]. The other RCT found no ef-
fect of intervention on the number of self-initiated adjust-
ments to the insulin regimen relative to a control [12].
Schiaffini and colleagues [14] provided participants with
a standardised educational programme encouraging better
self-monitoring. Half of the participants also received ac-
cess to an online website and were encouraged to access it
monthly for personalised feedback. After five years,
intervention participants reported administering more in-
sulin boluses per day relative to baseline (4.2 ± 1.0 vs 3.3 ±
1.0, p = 0.03). In the study by Goyal and colleagues [12],
participants receiving access to a mobile self-monitoring
application reported 1.85 ± 2.3 participant-initiated ad-
justments to the insulin dose at baseline and 1.77 ±
2.7 after 12 months. Participants without access to the
app reported 2.08 ± 3.4 self-initiated adjustments at
baseline and 1.10 ± 1.3 at 12 months; these differences
were not significant (p = 0.25).
Of the non-RCTs, one study found improvements to
insulin administration following intervention [23]. The
other non-RCT found no association of adherence to
intervention with insulin administration [26].
Giani and colleagues [23] reported that participants
who were provided with a CGM for 6 months and used
it on average 6–7 days/week during that period, were
significantly less likely to report missing insulin doses
(18%) than those using it 0–5 days/week (47%, p = 0.02).
Mulvaney and colleagues [26] found that individuals
with good adherence to a mobile-phone based ecological
momentary assessment intervention (real time sampling
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of behaviours/experiences) reported similar missed (rs =
0.14, p = 0.92) and correct (rs = 0.09, p = 0.54) insulin
doses to those with low adherence.
Interventions reporting on dietary management behaviour
No studies included dietary management behaviour as
an outcome.
Interventions reporting on physical activity behaviour
One of the included studies targeted physical activity as
an outcome [27]. This study demonstrated moderate risk
of bias (Table 1).
Study characteristics This study used weekly text mes-
saging alongside provision of an open pedometer to en-
courage participants to reach 10,000 steps a day over 12
weeks (n = 78; 47% male). Participants aged between 11
to 18 years were recruited from four adolescent diabetes
outpatient services in New Zealand. Measures included
pedometer step count, and self-reported physical activity
using the New Zealand Physical Activity Questionnaire
and SPARC-Long Physical Activity Questionnaire.
Effect of intervention on physical activity levels The
study found a non-significant trend towards decreased
daily step count in both intervention (CI = 1407 to 1364)
and control groups (CI = 1947 to 266, p = 0.4), following
12 weeks of intervention. A non-significant trend to-
wards increased self-reported physical activity was evi-
dent in both groups (intervention: + 48.4 min/week,
control: + 38.5 min/week more, p = 0.9).
Interventions reporting on glycaemic control (HbA1c)
A total of ten RCTs [28–37] and three non-RCTs [38–40]
measured HbA1c as a clinical indicator of diabetes
self-management. Five of the RCTs demonstrated low risk
[28, 33–35, 37] three RCTs had unknown risk [29, 30, 36],
one RCT had moderate risk [32] and one had
moderate-high risk of bias [31]. Of the non-RCTs, two
demonstrated a moderate risk of bias [38, 40] and one
demonstrated a high risk of bias [39].
Study characteristics Sample sizes ranged from 12 to
332 participants. The proportion of male participants
ranged from 35.5 to 57%. All samples were recruited
from paediatric clinics at one or more hospitals. The age
of participants ranged from 3 to 21 years. All partici-
pants were receiving treatment from a paediatric clinic
and/or described as adolescents or children.
Interventions included text messaging [n = 3 [29, 34, 36]],
mobile phone applications [n = 3 [30, 38, 39]]
telephone-delivered programmes [n = 1 [35]], video tapes
[n = 1 [37]], websites [n = 1 [40]], interactive online tools [n
= 3 [31–33]] and USB kitchen scales [n = 1 [28]].
Two RCTs found positive intervention effects on
HbA1c [34, 36]. Seven RCTs found no effect of interven-
tion on glycaemic control [28–32, 35, 37]. One study
provided only descriptive statistics and did not conduct
statistical analyses of these data [33].
Franklin and colleagues [34] reported a significant im-
provement in HbA1c following 12 months of text messa-
ging support (1–2 messages per day) and intensive
insulin therapy relative to a control group (9.2 ± 2.2,
95%CI = − 1.9, − 0.5, p < 0.001). Similarly, Rami and col-
leagues [36] used a randomised crossover design to
examine the efficacy of a telemedical support system
encouraging SMBG. HbA1c significantly improved in
the intervention group (intervention first group: 9.05%
[8–11.3%] at baseline, 8.9% [6.9–11.3%] at 3 months,
and 9.2% [7.4–12.6%] at end, intervention second group:
8.9% [8.3–11.6%], 9.9% [8.1–11%], and 8.85% [7.3–11.7%],
p < 0.05). Conversely, Nordfeldt and colleagues [37] did
not find any differences in change in HbA1c between
groups receiving personalised video tapes, generalised
video tapes or traditional care (values not reported). Simi-
larly, Berndt and colleagues [30] found no difference in
improvements in HbA1c between groups receiving
four weeks of access to a mobile phone application for
24-h self-monitoring and feedback, relative to a control
group (8.96% ± 2.23 to 7.99% ± 1.26 vs. 8.84 ± 1.71 to
8.12% ± 1.1 p = n.s.). Kowalska and colleagues [28] pro-
vided patients with a nutritional database and a USB kit-
chen scale for 26 weeks. Relative to a control group the
intervention group showed no change in HbA1c over time
after 3 months (7.2 ± 1.1 vs. 7.6 ± 1.1, p = 0.09) or 6
months (7.4 ± 1.2 vs. 7.6 ± 0.8, p = 0.16). Nunn and col-
leagues [35] found no difference in the change in HbA1c
between a group receiving bimonthly telephone support
delivering an educational programme and a usual care
group (8.15% ± 1.14 to 8.85% ± 1.29 vs. 8.32% ± 1.01 to
8.82% ± 1.10, p = 0.24). Similarly, Mulvaney et al., [32]
found no difference in change over time between a group
receiving six multimedia stories over 11 weeks and
prompts to complete problem-solving tasks, and a usual
care group (9.1% ± 1.9 to 9.1% ± 1.8 vs. 8.2 ± 1.2 to 8.5% ±
1.3, p = 0.27). Han and colleagues [29] reported no differ-
ence in HbA1c change in groups receiving
symptom-related text messages (− 0.37, d = 0.39, p =
0.12), symptom and knowledge-related text messages
(− 0.03, d = 0.04, p = 0.46), and standard care alone (−
0.21, d = 0.47, p = 0.87). Boogerd et al., [31] reported no
differences in change over time between a group receiv-
ing nine months of access to an online interactive inter-
vention and a group receiving usual care (F[1,61] =
0.16, p = 0.69). Whittemore and colleagues [33] re-
ported a trend towards maintaining stable HbA1c at
three and six months in a group receiving an internet
coping skills program. Alternatively, a control group
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showed a trend towards increasing HbA1c. Statistical
analysis of this outcome was not conducted.
One non-RCT found positive intervention effects on
HbA1c [39]. One non-RCT found no effects [38] and one
found positive associations with HbA1c but only when en-
gagement with the intervention was considered [40].
Mulvaney et al., [39] found a significant interaction be-
tween group and time in a study comparing patients re-
ceiving ten text messages per week for three months and
a matched historical control group (8.8% ± 2.1 to 8.8% ±
2.1 vs. 9.9% ± 2.3 to 8.92% ± 2.2, p = 0.01). Similarly,
Pinsker and colleagues [40] found a significant improve-
ment in HbA1c in patients using an online portal and
educational materials relative to a group who did not
utilise their access to the portal (users: 10.5 to 9.1%;
non-users: 9.5 to 10.4%, p = 0.03). Conversely, Frøisland
and colleagues [38] found no changes in HbA1c after
giving children and young people access to a mobile
phone-based diabetes picture diary which linked auto-
matically to their glucometer (8.3% vs. 8.1%, p = 0.38).
Interventions reporting on psychosocial or cognitive
indicators of improved self-management
A total of ten RCTs measured psychosocial or cognitive
indicators of self-management [15, 18, 30–35, 41, 42]
Five of these studies demonstrated low risk of bias
[15, 18, 33–35] one demonstrated moderate risk [32],
one study demonstrated moderate-high risk [31] and
three RCTs had unknown risk of bias [30, 41, 42].
Study characteristics Sample sizes ranged from 12 to
320 participants. The proportion of male participants
ranged from 35.5 to 57%. All samples were recruited
from paediatric clinics at one or more hospitals. The age
of participants ranged from three to 21 years. Two of the
studies included participants aged over 18 years. Both
were receiving treatment from a paediatric clinic and/or
described as adolescents.
Interventions included mobile phone applications [n = 1
[30]], telephone call support [n = 1 [35]], videoconferenc-
ing [n = 1 [41]], text messaging [n = 2 [32, 34]],
internet-based programs [n = 4 [15, 18, 31, 33]] and per-
sonal robots [n = 1 [42]].
Six studies measured self-efficacy for diabetes manage-
ment using the Diabetes Self-Efficacy Scale, the
Self-Efficacy for Diabetes Scale, the Self-Efficacy for Dia-
betes Management Measure or the Confidence in Diabetes
Self-Care Questionnaire. One study employed a measure
of self-determination constructs via the Basic Need Satis-
faction in Relationships Scale. One study used the Working
Alliance Inventory to provide a measure of the relationship
between the child and their clinical team. Four studies
measured change in diabetes knowledge using the Diabetes
Knowledge Questionnaire, Diabetes Knowledge Score, Test
of Diabetes Knowledge and a bespoke 30-question meas-
ure. One study measured problem solving ability via the
Diabetes Problem Solving Behaviours Scale.
Four studies found improvements in at least one of
the psychological or cognitive parameters measured in
their studies following intervention [18, 30, 34, 42].
Alternatively, six studies found no improvements after
receiving an intervention [15, 31–33, 35, 41].
Berndt and colleagues [30] found a significant improve-
ment in self-efficacy in a group of young patients encour-
aged to use “Mobil Diab”, a mobile diabetes management
system, three times a day for four weeks (7.54 ± 0.85 to
8.04 ± 1.22, p = 0.04). A comparison group receiving usual
care did not significantly improve their self-efficacy (7.22
± 1.64 to 7.65 ± 1.24, p = 0.12). In a study by Henkemans
and colleagues [42] participants played games with a neu-
tral robot or a personal robot during three consecutive
clinic visits. Following the third session, participants play-
ing with the personal robot demonstrated higher
self-reported need satisfaction (Z = 2.33, p = 0.02). Partici-
pants playing with the robot also answered significantly
more questions correctly than those who did not play the
quiz (F [1, 45]=7.27, p = 0.00). Franklin and colleagues
[34] reported greater improvements in self-efficacy
(95%CI: 2.6, 7.5, p = 0.00) in a group receiving 1–2 text
messages a day via “Sweet Talk” than a group receiving
usual care, but not in diabetes knowledge (95%CI: -1.5,
1.4, p = 0.3). Whittemore and colleagues [18] reported a
significant increase in self-efficacy of children and young
people receiving five weekly online cognitive skills sessions
(TEENCOPE) and another group given access to a generic
diabetes website (p < 0.001). Other studies of TEENCOPE
found no better outcomes than alternative treatments.
Whittemore and colleagues [33] found non-significant
trends towards improved self-efficacy after five weekly
cognitive skills sessions delivered online (55.5 to 39.0, p =
0.20). Whittemore and colleagues [15] later conducted an-
other study, which combined the earlier developed TEEN-
COPE with an online problem solving program and found
no effect of intervention or a generic website on
self-efficacy (SE = − 1.20 ± 0.84 vs. -0.43 ± 0.85, p = 0.52).
Boogerd and colleagues [31] reported no difference in
change over time for self-efficacy (F[1,61] = 2.55, p = 0.12)
or diabetes knowledge (F[1,61] = 0.09, p = 0.77) between a
group receiving a nine-month online interactive treatment
called Sugarsquare, relative to a group receiving regular
emails. Freeman and colleagues [41] found no difference
in working alliance (221.62 vs. 224.84, p = 0.53) following
ten behavioural health care sessions delivered via Skype or
in clinic. Mulvaney and colleagues [32] found six tailored
multimedia stories over 11 weeks to have no differential
effect on problem solving ability relative to usual care
alone (3.5 ± 0.5 to 3.6 ± 0.5 vs. 3.4 ± 0.6 to 3.3 ± 0.7, p =
0.23). Nunn and colleagues [35] reported no difference
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in change in diabetes knowledge following 7 months
of bimonthly supportive telephone discussions or con-
tinuing usual care (79.1 ± 57.4 to 84.5 ± 52.7 vs. 77.5
± 55.7 to 82.4 ± 55.6, p = 0.34).
Discussion
This review demonstrates that technology-based health in-
terventions can exert minor positive influences on SMBG
(as a behavioural outcome), psychological or cognitive out-
comes, and clinical indicators of diabetes self-management
(e.g. HbA1c). Physical activity and dietary practices are
rarely targeted by technology-based interventions and al-
most never measured as outcomes, despite evidence from
non-technology-based interventions of positive effects on
the management of T1DM in children and young people
[43, 44]. Technology-based interventions that target phys-
ical activity and dietary behaviours in studies that measure
these factors as outcomes, are therefore encouraged.
The most positive finding was that the majority of stud-
ies exploring SMBG behaviour found that children and
young people monitored their blood glucose more fre-
quently following exposure to technology-based interven-
tions. This is important since greater self-monitoring
frequency is associated with better diabetes management
[45]. However, only three of these studies produced results
that were deemed to be clinically relevant (Table 1). In the
case of two of these studies this may be explained by the
longer follow-up period used relative to that in other in-
cluded studies [14, 25]. The third study with positive find-
ings for SMBG only recruited patients who were not
adherent to their existing self-management routine, and
so may have had greater potential for demonstrating out-
come improvement [13]. Future studies should therefore
test interventions over a period of at least one year and
may wish to target non-adherers.
Psychosocial and cognitive supports have also been as-
sociated with better diabetes outcomes [46–48]. Approxi-
mately half of the studies including measures of glycaemic
control and/or cognitive or psychosocial parameters re-
ported positive intervention effects. Positive changes were
most common for self-efficacy. This is an important find-
ing as self-efficacy has previously been identified as one of
the most important predictors of disease management in
children with chronic disease [49]. Future research in this
area may seek to include technology-based interventions
that aim to build self-efficacy specifically. However, none
of the findings in the included studies were deemed to be
clinically significant. The articles failing to report positive
outcomes tended to involve a smaller study sample and
scored lower on study quality, and as such they may have
lacked power or sensitivity to detect changes. There is a
need for high-quality research evidence with more
complete descriptions of blinding procedures, outcome
reporting and usual care, in order to fully assess the
impact of technology-based interventions on glycaemic
control and psychosocial/cognitive outcomes.
None of the studies found usual care alone to produce
better outcomes than intervention conditions. While
usual care must always be provided where possible, tech-
nology interventions could be useful in instances when
the delivery of usual care is interrupted beyond the con-
trol of healthcare practitioners. For instance, if a patient
frequently misses clinic appointments or is planning a
trip away from their regular clinical care team, then
technological interventions may be helpful in maintain-
ing the delivery of key processes, such as HbA1c moni-
toring, provision of key information, goal setting etc.,
which might otherwise be missed. This could also apply
to common transitional events during which usual care
could be interrupted, such as family moves to new
catchment areas (for schools and hospitals) and in later
years the young person moving away to college or uni-
versity [50]. Further, given evidence reported in a previ-
ous study by Petry et al. [51] that monetary reinforcers
encourage greater SMBG of adolescents over a 12-week
period, technology could be investigated as a tool for in-
creasing longevity of reward effects, through facilitating
delivery of rewards or even replacing monetary rewards
with digital ones, given adolescents affinity for techno-
logical devices. This review suggests some promise for
the use of technology-based interventions to promote
aspects of the NICE guidance, but urges caution as evi-
dence of efficacy is currently equivocal.
For the majority of included outcomes, clinical rele-
vance was deemed to be little or none. Three studies
demonstrated some to high clinical relevance for SMBG
[13, 14, 25]. Many of the studies had methodological
weaknesses or were poorly reported. A number of stud-
ies were ostensibly looking at the frequency of
self-monitoring of blood glucose (SMBG) but did not
give information on the actual number of blood glucose
tests performed, or they relied on self-reporting of ad-
herence to SMBG, which is well recognised as not al-
ways being reliable in young people with diabetes.
Where HbA1C was used as an outcome measure, there
was generally no difference between intervention and
control groups or inappropriate control groups were used.
In those studies where clinically meaningful outcomes
were reported there was also significant direct personal
intervention from the study team. This makes it very diffi-
cult to determine whether it was the technology or the
additional contact from the study team which led to any
improvements. Full details regarding clinical relevance of
findings are provided in Table 1.
The majority of included studies were RCTs all of which
were randomised at participant level. It is therefore impos-
sible to estimate contamination bias of studies though this
is likely to be low as interventions were predominantly
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delivered via personal devices. Participant characteristics
in the control and intervention conditions at baseline were
similar in most studies, however the variables measured
varied in depth and type. Where found, differences were
minor and were statistically controlled in comparative
analysis, but the risk of subsequent bias in intervention
outcomes remains. Just under half of included studies re-
ported employing an intention-to-treat analysis, the re-
mainder may have employed this type of analysis but
failed to report it. It is therefore unclear to what extent se-
lection bias has influenced findings.
The inclusion of non-RCTs increased the depth of the
review but also the potential for researcher bias and this
may have obscured interpretation of effectiveness.
Level of contact with the technology under investigation
varied greatly between interventions, from multiple times
per day to single follow-up time points. It is therefore
challenging to attribute the success of a particular inter-
vention to a specific intervention component. More than
half of the studies assessed outcomes over the medium
term (six months to one year). Although attrition ap-
peared to be higher in studies involving a potentially
greater burden of time or scheduled interactivity for the
participant (e.g. videoconferencing), attrition across the
studies was generally low. This supports previous findings
that technology based interventions are generally
well-accepted by children and young people with T1DM
[4].
One focus of future research could be to increase the em-
phasis on the behaviour change aspect of technology-based
health interventions for children and young people with
T1DM. Evidence of efficacy tended to be stronger when ad-
herence to the intervention was considered. However, few
studies explicitly framed their interventions in behaviour
change theory (or reported doing so), though it is
possible that theoretical components were used in the
development of messages. Future studies should en-
sure that interventions are developed and framed in
the context of current behaviour change theory and
that this aspect is well reported.
There is a need to examine technologies aiming to
promote healthy lifestyle behaviours that are advocated
in NICE guidelines and known to influence diabetes
management outcomes. For example, physical activity is
a beneficial health behaviour for all young people gener-
ally and for those with T1DM specifically due to its role
in promoting insulin efficiency and glycaemic control.
Children and young people with T1DM tend to fall short
of physical activity guidelines and may be less active
than their peers without T1DM [52]. There is some
existing evidence demonstrating the potential feasibility
and acceptability of technology-based studies on physical
activity behaviours in paediatric diabetic populations [4]
although this needs to be further investigated.
Only articles published in the English language were
included; thus, other relevant studies in other languages
may have been missed. Due to publication bias it is also
possible that relevant findings were missed [53]. As no
studies measuring dietary management behaviours fitted
our inclusion criteria, and very few studies measured
physical activity or insulin administration, meaningful
conclusions regarding these outcomes are precluded.
The present review included a wide age range to be as
inclusive as possible, however, we acknowledge that the
outcomes of interventions will be influenced by age. Fi-
nally, it was the intention of this review to take a behav-
ioural standpoint. Therefore, the focus here is on the
self-management behaviours and prerequisites most
likely to be targeted by technology-based interventions
and measured as outcomes, as opposed to focusing on
the types of technologies utilised. Whilst this may be a
limitation of this review, other systematic reviews have
provided this perspective. This review offers a novel ap-
proach to the use of technology to advocate the behav-
iours and prerequisites specified in the current NICE
guidance for the self-management of paediatric T1DM.
Conclusions
NICE guidance proposes a number of key behaviours
[2], prerequisites and predictors to the effective manage-
ment of T1DM. Published evidence around the use of
technology-based interventions has neglected to include
or report on outcomes pertaining to some of these (e.g.
diet, physical activity and insulin administration). We
identified a number of efficacious studies indicating
promise for the use of technology as a platform to
deliver self-management interventions, specifically for
SMBG and building self-efficacy. Further, technology-
based interventions performed no worse than usual care
alone in all studies and attrition was generally low in-
dicating patient acceptability. As such, we conclude
that technology-based interventions may have merit
for promoting some of the guideline objectives for
the management of T1DM in children and young
people. Further work is needed to ascertain which el-
ements of interventions are most likely to produce
clinically relevant outcomes.
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